Arvinas, Inc. (ARVN) SEC Filings — 2024

Filings

• Arvinas, Inc. Signs Material Definitive Agreement — 8-K · Dec 16, 2024
• Arvinas, Inc. Files 8-K Report — 8-K · Dec 10, 2024
• Arvinas, Inc. Files 8-K Report — 8-K · Nov 19, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Arvinas Q3 2024 10-Q Filed — 10-Q · Oct 30, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Sep 10, 2024
• Arvinas, Inc. Signs Material Definitive Agreement — 8-K · Aug 20, 2024
• Arvinas, Inc. Files Q2 2024 Quarterly Report — 10-Q · Jul 30, 2024
• Arvinas Appoints New CMO, Elects Director — 8-K · Jun 24, 2024
• Arvinas, Inc. Signs Material Definitive Agreement — 8-K · Jun 18, 2024
• Arvinas Appoints New CMO, Dr. McCluskey — 8-K · Jun 17, 2024
• Arvinas Partners with Eli Lilly for $1.08B Drug Development Deal — 8-K · May 30, 2024
• Arvinas, Inc. Files 8-K Report — 8-K · May 16, 2024
• Arvinas, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
• Arvinas, Inc. Files Definitive Proxy Statement for 2024 Annual Meeting — DEF 14A · Apr 16, 2024
• Arvinas, Inc. Files 8-K for Material Definitive Agreement — 8-K · Apr 11, 2024
• Arvinas Board Changes and Executive Compensation Update — 8-K · Mar 18, 2024
• Arvinas, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
• Arvinas Files 8-K on Officer Changes and Compensation — 8-K · Feb 20, 2024
• Arvinas, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Arvinas, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Arvinas, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• BlackRock Maintains Significant Stake in Arvinas, Inc. — SC 13G/A · Jan 26, 2024
• Arvinas Files 8-K for Jan 7 Event; Details Pending — 8-K · Jan 8, 2024